xRNA2023 会议介绍 Conference Introduction 作为精准医疗的有效手段之一, 核酸药物能够直接作用于靶基因或者靶mRNA, 从根源上调控致病基因的表达. 小核酸药物极大的扩展了创新药物的可选择靶点范围, 使得过去不可成药的靶点变为可能. 近年来, 随着化学修饰, 核酸递送及生产技术的不断成熟, RNA药物发展显著提速, 多款...
战略媒体丨RNAScript、猎药人俱乐部 会议网址丨www.xrnatherapeutics-innovation.com 会议主要专题: 专题一:mRNA与环状RNA疫苗与药物研发 专题二:mRNA疫苗工艺开发与质量研究 专题三:mRNA肿瘤疫苗与创新应用 专题四:小核酸药物研发与CMC开发 专题五:核酸药物递送策略与技术 2023 部分已确认演讲嘉宾 添加工作人员微信获取...
RNA therapeutics, a ground-breaking field in medicine, hold the promise of revolutionising the way we treat a wide array of diseases. At the heart of this innovation is the utilisation of ribonucleic acid (RNA) molecules, the genetic messengers responsible for carrying out vital cellular functions...
The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry's leading role in developing vaccines against COVID-19 in response to the global pandemic. This year's conference will reflect on how the industry has adapted and pl...
Introducing the only RNA therapeutics conference to hold a full day exploring alternatives to oligonucleotide delivery systems. The global antisense and RNA therapeutics market is expected to expand at a compound annual growth rate (CAGR) of 8.6% between 2019 and 2025, projected to reach $1.81 bill...
changing the proportions of siRNA triggers against HBs and HBx according to clinical virus parameters of patients may help improve therapeutic outcome. Next, while the rAAV-HBV1.3 model is the most studied model of chronic HBV infection for investigating the effects of anti-HBV therapeutics, it ...
Such approaches can directly target the stability of mRNAs or modulate non-coding RNA-mediated regulation of transcription and translation. This Review highlights emerging RNA-targeted therapeutics for gene activation, focusing on opportunities and challenges for translation to the clinic....
The Second International Conference on RNA Nanotechnology and TherapeuticsLeontis, NSweeney, BHaque, FGuo, P X
formulate and promote our offerings from basic medicinal research, discovery to development till commercialization. Our current programs cover Drug Discovery, Clinical Development, Biomarkers and Companion Diagnostics, Antibody The...
Development of new RNAi therapeutics. RNAi-mediated gene inactivation has become a cornerstone of the present day gene function studies that are the foundation of mechanism and target based dru... G Liu,F Wongstaal,QX Li - 《Histology & Histopathology》 被引量: 153发表: 2007年 Small Non-Codi...